Hoofddorp, the Netherlands, 30 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2020 annual report.
Minutes of the Extraordinary General Meeting of IGEA Pharma N.V., a public limited company (naamloze vennootschap), having its registered office in Amsterdam (the Netherlands) and address at (2132 WT) Hoofddorp, Siriusdreef 17, registered with the Commercial Register of the Chamber of Commerce under number 70212821, held virtually on 28 April 2021.
Hoofddorp, the Netherlands, 28 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that the extraordinary general meeting unanimously approved all the Board of directors’ proposals. The minutes of the meeting is available at https://www.igeapharma.nl/category/information-for-shareholders/
Hoofddorp, the Netherlands, 15 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the signing of a two-year convertible bond commitment with UAE-based Negma Group.